| |
 |
|
|
|
|
|
Poster: 660
Visits: 59
Title: PHARMACOKINETICS AND PHARMACODYNAMICS OF LEXAPTEPID, A NOVEL ANTI-HEPCIDIN MOLECULE, IN ESA-RESISTANT HAEMODIALYSIS PATIENTS
Authors: Iain C. Macdougall , Iain C. Macdougall1, Adam Rumjon1, Jake Cinco1, Leela Goldstein1,Luciana Summo2, Stéphanie Vauléon2, Kai Riecke2
Centre: 1: Department of Renal Medicine, Kings College Hospital, London, UK; 2: Clinical Development, NOXXON Pharma AG, Berlin, Germany
|
|
You must be registered to reply or comment.
|
|
PHARMACOKINETICS AND PHARMACODYNAMICS OF LEXAPTEPID, A NOVEL ANTI-HEPCIDIN MOLECULE, IN ESA-RESISTANT HAEMODIALYSIS PATIENTS
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 625
Visits: 3858
Title: IS 4 CITRATE AN EFFECTIVE TOOL AS A CATHETER LOCKING SOLUTION?
Authors: Joao Fazendeiro Matos ,
Centre: Fresenius Medical Care | NephroCare Portugal
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 658
Visits: 209
Title: JTZ-951, A NOVEL HIF-PHD INHIBITOR, DEMONSTRATES INCREASES IN HEMOGLOBIN, IRON MOBILIZATION, REPRODUCIBLE PHARMACOKINETICS, AND SAFETY FOLLOWING ONCE DAILY ADMINISTRATION FOR 15 DAYS IN PATIENTS WITH ANEMIA RECEIVING HEMODIALYSIS
Authors: Sudhakar Pai , R. Koretomo, S. Tamaki, J. Berg, T. Marbury, C. Galloway, R. Preston
Centre: Akros Pharma, Inc.
|
|
|
|
